D-TARGET SA Company Profile

21:12 EDT 22nd March 2018 | BioPortfolio

Stratigically located in Switzerland, the heart of Europe, D-TARGET is the number one clinical research organisation specializing in Clinical and Regulatory Services throughout the European continent.
Medical device manufacturers worldwide rely upon D-TARGET's highly trained, multi-lingual professionals for result-oriented solutions in bringing their products to life in more than 25 European countries


En Chamard 55C



News Articles [205 Associated News Articles listed on BioPortfolio]

Bristol-Myers Squibb Extends Partnership with Target PharmaSolutions for TARGET-NASH

CHAPEL HILL, N.C, Oct. 12, 2017 /PRNewswire/ — TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Bristol-Myers Squibb (BMY) has extended its strategic...

Performance on A&E target slips further

NHS hospital performance against the four-hour A&E target stood at just 74.96 percent, well under the 95 percent target, for the week ending March 11th, show the most recent data from the Royal Co...

Boehringer Ingelheim partners with TARGET to progress NASH research

TARGET PharmaSolutions announced that Boehringer Ingelheim International has entered into a multi-year strategic partnership for TARGET-NASH.

CRISPR Does it Again! Gene Editing Tool Identifies a New Leukemia Target

Researchers from the Wellcome Trust Sanger Institute have reported that a new target for the treatment of leukemia has been found.  A new drug target for acute myeloid leukemia (AML) has been identi...

Purification‐Free, Target‐Selective Immobilization of a Protein from Cell Lysates

Protein immobilization has been widely used for laboratory experiments and industrial processes. Preparation of a recombinant protein for immobilization usually requires laborious and expensive purifi...

Boehringer Ingelheim Partners with Target PharmaSolutions to Progress NASH Research

CHAPEL HILL, N.C., Oct. 19, 2017 /PRNewswire/ — TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Boehringer Ingelheim International GmbH has entered ...

26 Tweets That Will Make Sense If Your S.O. Is Obsessed With Target

When you fall in love with a Target devotee, you’ll only ever have half of their heart.

Managing Expectations: "We're Still On Target" Says AstraZeneca CEO

Pascal Soriot says AstraZeneca remains on track to hit its $45bn sales target in 2023 – more or less -...   

PubMed Articles [667 Associated PubMed Articles listed on BioPortfolio]

Effects of seed mixture sowing with resistant and susceptible rice on population dynamics of target planthoppers and non-target stemborers and leaffolders.

The widespread planting of insect-resistant crops has caused a dramatic shift in agricultural landscapes, thus raising concerns about the potential impact on both target and non-target pests worldwide...

What is the optimal target for treat-to-target strategies in rheumatoid arthritis?

There has been a trend over time to aim for stricter treatment targets in the treatment of rheumatoid arthritis (RA). We reviewed recent literature to attempt to identify the optimal target in treat-t...

Discriminative Multiple Instance Hyperspectral Target Characterization.

In this paper, two methods for discriminative multiple instance target characterization, MI-SMF and MI-ACE, are presented. MI-SMF and MI-ACE estimate a discriminative target signature from imprecisely...

Crowding and perceptual organization: Target's objecthood influences the relative strength of part-level and configural-level crowding.

In visual crowding, identification of a peripheral object is impaired by nearby objects. Recent studies have demonstrated that crowding is not limited only to interaction between low-level features or...

Abundant off-target edits from site-directed RNA editing can be reduced by nuclear localization of the editing enzyme.

Site-directed RNA editing (SDRE) is a general strategy for making targeted base changes in RNA molecules. Although the approach is relatively new, several groups, including our own, have been working ...

Clinical Trials [1507 Associated Clinical Trials listed on BioPortfolio]

Treat Stroke to Target

The aim of this study is the evaluation of two usual care strategies after stroke or TIA : achieved target LDL-C of 100 mg/dL (+/-10 mg/dL) or less than 70 mg/dL. Investigators will use th...

Reduction of Remifentanil-related Complications by Limiting Maximum Plasma Concentration During Target-controlled Infusion

This study is intended to evaluate the effect of decreasing the maximum plasma concentration target of remifentanil of the Target Controlled Infusion system on the the incidence of major a...

BP-TARGET : Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy

A randomized, multicenter study comparing two strategies: 1 / standard management of systolic blood pressure according to international recommendations (systolic blood pressure

Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)

In this study the effect of the switch to rosuvastatin from another statin (fluvastatin, pravastatin, simvastatin, atorvastatin) was evaluated in high-risk patients with and without eviden...

Evaluation of Target Organs Damage in Hypertensive Patients

Evaluation of target organs damage in hypertensive patients with no known cardiovascular (CV) or renal disease, stratified according to level of blood pressure control

Companies [594 Associated Companies listed on BioPortfolio]

Target Health Inc. & LifeOnKey Inc.

Target Health, ( established in 1993, is a full service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of exp...

Target Corp.

Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,764 stores across the United States and at The company plans to open its first stores in Canada in 2...

Target Corporation

Minneapolis-based Target Corporation (NYSE: TGT) serves guests at 1,699 stores in 49 states nationwide and at Target is committed to providing a fun and convenient shopping experience with...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founde...


Stratigically located in Switzerland, the heart of Europe, D-TARGET is the number one clinical research organisation specializing in Clinical and Regulatory Services throughout the European continent....

More Information about "D-TARGET SA" on BioPortfolio

We have published hundreds of D-TARGET SA news stories on BioPortfolio along with dozens of D-TARGET SA Clinical Trials and PubMed Articles about D-TARGET SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of D-TARGET SA Companies in our database. You can also find out about relevant D-TARGET SA Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Corporate Database Quicklinks

Searches Linking to this Company Record